US 11479576
Nucleic acid prodrugs
granted A61PA61P1/00A61P1/16
Quick answer
US patent 11479576 (Nucleic acid prodrugs) held by AVALO THERAPEUTICS, INC. expires Mon Oct 20 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- AVALO THERAPEUTICS, INC.
- Grant date
- Tue Oct 25 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 20 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 3
- CPC classes
- A61P, A61P1/00, A61P1/16, A61P21/00, A61P25/00